On Nov. 1, the White House published a fact sheet outlining some details of the U.S.-China trade agreement. The United States will remove 10 percentage points from the IEEPA Fentanyl tariff rate on goods from China effective Nov. 10, 2025. The U.S. has agreed to maintain the current 10% reciprocal tariff through Nov. 10, 2026.
This brings the total effective IEEPA tariff rate for goods that are entered beginning on Nov. 10, 2025, to a total of 20%: 10% for IEEPA fentanyl and 10% for IEEPA reciprocal. The administration will also extend certain Section 301 tariff exclusions, originally set to expire Nov. 29, 2025, to Nov. 10, 2026.
The U.S. will also pause for one year, beginning Nov. 10, 2025, both the implementation of the “Expansion of End-User Controls” rule and the Section 301 actions tied to China’s maritime, logistics and shipbuilding industries. During this period, the U.S. will continue negotiations with China and advance its shipbuilding initiatives alongside South Korea and Japan.
In return, China agreed to roll back a wide range of trade and export restrictions, including suspending recent rare-earth export controls, lifting retaliatory tariffs and non-tariff measures on U.S. goods and companies, and ending export-related investigations into U.S. semiconductor firms. China will also resume and expand purchases of key U.S. agricultural products, including soybeans, sorghum and hardwood logs, and ensure chip production from facilities can continue to supply global markets. China also committed to curbing shipments containing the chemicals that are used to make fentanyl and will extend tariff exclusions for U.S. imports through the end of 2026.
